Literature DB >> 18493257

Suppression of stroke-induced progenitor proliferation in adult subventricular zone by tumor necrosis factor receptor 1.

Robert E Iosif1, Henrik Ahlenius, Christine T Ekdahl, Vladimer Darsalia, Pär Thored, Stefan Jovinge, Zaal Kokaia, Olle Lindvall.   

Abstract

Stroke induced by middle cerebral artery occlusion leads to transiently increased progenitor proliferation in the subventricular zone (SVZ) and long-lasting striatal neurogenesis in adult rodents. Tumor necrosis factor-alpha (TNF-alpha) is upregulated in stroke-damaged brain. Whether TNF-alpha and its receptors influence SVZ progenitor proliferation after stroke is unclear. Here we show that the increased proliferation 1 week after stroke occurred concomitantly with elevated microglia numbers and TNF-alpha and TNF receptor-1 (TNF-R1) gene expression in the SVZ of wild-type mice. TNF receptor-1 was expressed on sorted SVZ progenitor cells from nestin-green fluorescent protein reporter mice. In animals lacking TNF-R1, stroke-induced SVZ cell proliferation and neuroblast formation were enhanced. In contrast, deletion of TNF-R1 did not alter basal or status epilepticus-stimulated cell proliferation in SVZ. Addition of TNF-alpha reduced the size and numbers of SVZ neurospheres through a TNF-R1-dependent mechanism without affecting cell survival. Our results provide the first evidence that TNF-R1 is a negative regulator of stroke-induced SVZ progenitor proliferation. Blockade of TNF-R1 signaling might be a novel strategy to promote the proliferative response in SVZ after stroke.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18493257     DOI: 10.1038/jcbfm.2008.47

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  43 in total

Review 1.  Targeting TNF-α to elucidate and ameliorate neuroinflammation in neurodegenerative diseases.

Authors:  Kathryn A Frankola; Nigel H Greig; Weiming Luo; David Tweedie
Journal:  CNS Neurol Disord Drug Targets       Date:  2011-05       Impact factor: 4.388

Review 2.  Immune influence on adult neural stem cell regulation and function.

Authors:  Pamela A Carpentier; Theo D Palmer
Journal:  Neuron       Date:  2009-10-15       Impact factor: 17.173

3.  Opposite effect of inflammation on subventricular zone versus hippocampal precursors in brain injury.

Authors:  Matthew V Covey; Dean Loporchio; Krista D Buono; Steven W Levison
Journal:  Ann Neurol       Date:  2011-06-27       Impact factor: 10.422

Review 4.  Tumor necrosis factor-alpha and the roles it plays in homeostatic and degenerative processes within the central nervous system.

Authors:  Sara L Montgomery; William J Bowers
Journal:  J Neuroimmune Pharmacol       Date:  2011-07-05       Impact factor: 4.147

Review 5.  Cross-talk between neural stem cells and immune cells: the key to better brain repair?

Authors:  Zaal Kokaia; Gianvito Martino; Michal Schwartz; Olle Lindvall
Journal:  Nat Neurosci       Date:  2012-07-26       Impact factor: 24.884

6.  The Levels of Inflammatory Markers in the Treatment of Stroke study (LIMITS): inflammatory biomarkers as risk predictors after lacunar stroke.

Authors:  M S V Elkind; J M Luna; C S Coffey; L A McClure; K M Liu; S Spitalnik; M C Paik; A Roldan; C White; R Hart; O Benavente
Journal:  Int J Stroke       Date:  2010-04       Impact factor: 5.266

7.  Demyelination-Induced Inflammation Attracts Newly Born Neurons to the White Matter.

Authors:  Samah Kalakh; Abdeslam Mouihate
Journal:  Mol Neurobiol       Date:  2016-09-23       Impact factor: 5.590

Review 8.  Targeting Tumor Necrosis Factor Alpha for Alzheimer's Disease.

Authors:  Boris Decourt; Debomoy K Lahiri; Marwan N Sabbagh
Journal:  Curr Alzheimer Res       Date:  2017       Impact factor: 3.498

Review 9.  Forebrain neurogenesis after focal Ischemic and traumatic brain injury.

Authors:  Steven G Kernie; Jack M Parent
Journal:  Neurobiol Dis       Date:  2009-11-10       Impact factor: 5.996

10.  High-dose lovastatin for acute ischemic stroke: results of the phase I dose escalation neuroprotection with statin therapy for acute recovery trial (NeuSTART).

Authors:  Mitchell S V Elkind; Ralph L Sacco; Robert B Macarthur; Ellinor Peerschke; Greg Neils; Howard Andrews; Joshua Stillman; Tania Corporan; Dana Leifer; Rui Liu; Ken Cheung
Journal:  Cerebrovasc Dis       Date:  2009-07-16       Impact factor: 2.762

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.